Pending pharmacokinetic studies of antiretroviral drugs in the elderly

2018-09-20
Philippe Morlat

Are there any pending pharmacokinetic studies of antiretroviral drugs in the elderly?

Philippe Morlat, MD, PhD: Not really. The main problem in elderly patients is polypharmacy, because they take many drugs against many comorbidities. There are a lot of trials which study the interactions between antiretroviral drugs and other medications that are taken by these people, but there are no pharmacokinetic studies which are predicted.

We would love to hear from you

  • Do you have any comments?
  • Have you found a mistake?
  • Would you like to suggest a feature?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.